Emergent BioSolutions to Participate in First Quarter 2018 Investor Conferences

GAITHERSBURG, Md., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences during the first quarter of 2018:

• J.P. Morgan & Co. – 36th Annual Healthcare ConferenceSan Francisco, CAJanuary 8-11, 2018

• RBC Capital Markets – 2018 Global Healthcare ConferenceNew York, NYFebruary 21-22, 2018

• Cowen & Co. – 38th Annual Health Care ConferenceBoston, MAMarch 12-14, 2018

Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under “Investors” as the information becomes available.

For these conferences, the company will be webcasting its presentation, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.

About Emergent BioSolutionsEmergent BioSolutions is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally emerging public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at www.emergentbiosolutions.com. Follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact:Robert G. BurrowsVice President, Investor Relations240-631-3280[email protected]

Media Contact:Lynn KiefferVice President, Corporate Communications240-631-3391[email protected]

Source: Emergent Biosolutions, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• Voya Financial estimates Q2 alternative investment pre-tax loss of $9M-$19M
• Deutsche Bank Downgrades Simon Property Group (SPG) to Hold